Results: 1-14 |
Results: 14

Authors: Schiller, G Wong, S Lowe, T Snead, G Paquette, R Sawyers, C Wolin, M Kunkel, L Ting, L Li, G Territo, M
Citation: G. Schiller et al., Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission, LEUKEMIA, 15(5), 2001, pp. 757-763

Authors: Esses, D Gallagher, EJ Iannaccone, R Bijur, P Srinivas, VS Rose, H Kunkel, L Sokolof, J
Citation: D. Esses et al., Six-hour versus 12-hour protocols for AMI: CK-MB in conjunction with myoglobin, AM J EMER M, 19(3), 2001, pp. 182-186

Authors: Byrd, JC Murphy, T Howard, RS Lucas, MS Goodrich, A Park, K Pearson, M Waselenko, JK Ling, G Grever, MR Grillo-Lopez, AJ Rosenberg, J Kunkel, L Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164

Authors: Wagner, TH Hibbard, JH Greenlick, MR Kunkel, L
Citation: Th. Wagner et al., Does providing consumer health information affect self-reported medical utilization? Evidence from the Healthwise Communities Project, MED CARE, 39(8), 2001, pp. 836-847

Authors: Atkins, MB Kunkel, L Sznol, M Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update, CA J SCI AM, 6, 2000, pp. S11-S14

Authors: Grillo-Lopez, AJ Kunkel, L
Citation: Aj. Grillo-lopez et L. Kunkel, Correspondence re: T. Davis et al, therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression. Clin. Cancer Res., 5 : 611-615, 1999., CLIN CANC R, 6(1), 2000, pp. 317-318

Authors: Kunkel, L Wong, A Maneatis, T Nickas, J Brown, T Grillo-Lopez, A Benyunes, M Grobman, B Dillman, RO
Citation: L. Kunkel et al., Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: A benefit-risk update, SEMIN ONCOL, 27(6), 2000, pp. 53-61

Authors: Saleh, MN Gutheil, J Moore, M Bunch, PW Butler, J Kunkel, L Grillo-Lopez, AJ LoBuglio, AF
Citation: Mn. Saleh et al., A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia, SEMIN ONCOL, 27(6), 2000, pp. 99-103

Authors: Perls, T Terry, DF Silver, M Shea, M Bowen, J Joyce, E Ridge, SB Fretts, R Daly, M Brewster, S Puca, A Kunkel, L
Citation: T. Perls et al., Centenarians and the genetics of longevity, RES PRO CEL, 29, 2000, pp. 1-20

Authors: Perls, T Shea-Drinkwater, M Bowen-Flynn, J Ridge, SB Kang, S Joyce, E Daly, M Brewster, SJ Kunkel, L Puca, AA
Citation: T. Perls et al., Exceptional familial clustering for extreme longevity in humans, J AM GER SO, 48(11), 2000, pp. 1483-1485

Authors: Kunkel, L
Citation: L. Kunkel, Caveolin-3 deficiency as a cause of limb-girdle muscular dystrophy, J CHILD NEU, 14(1), 1999, pp. 33-34

Authors: Atkins, MB Lotze, MT Dutcher, JP Fisher, RI Weiss, G Margolin, K Abrams, J Sznol, M Parkinson, D Hawkins, M Paradise, C Kunkel, L Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993, J CL ONCOL, 17(7), 1999, pp. 2105-2116

Authors: Hibbard, JH Greenlick, M Jimison, H Kunkel, L Tusler, M
Citation: Jh. Hibbard et al., Prevalence and predictors of the use of self-care resources, EVAL HEALTH, 22(1), 1999, pp. 107-122

Authors: Emmanouilides, C Rosen, P Rasti, S Territo, B Kunkel, L
Citation: C. Emmanouilides et al., Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: A phase II trial, HEMATOL ONC, 16(3), 1998, pp. 107-116
Risultati: 1-14 |